Cancer, Advanced Terminated Phase 1 / 2 Trials for Pembrolizumab (DB09037)

Also known as: Advanced Cancer / Cancer / Neoplasm malignant / Malignant neoplasm NOS / Cancer NOS / Malignant tumor / Malignant tumour / Cancer (NOS) / Malignant neoplasm without specification of site

DBCOND0041606 (Cancer, Advanced)Terminated1 / 2 IdentifierTitlePurposeDrugs
NCT02318901Pembrolizumab and Monoclonal Antibody Therapy in Advanced CancerTreatment
NCT02331251Study of Pembrolizumab Plus Chemotherapy in Patients With Advanced Cancer (PembroPlus)Treatment